AVEO PHARMACEUTICALS INC (AVEO) Stock Analyst Earnings Estimates
NASDAQ:AVEO - Nasdaq - US0535883070 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 28.8M 433.33% | 6M -79.17% | 42.295M 604.92% | 114.29M 170.22% | 184.75M 61.65% | 233.91M 26.61% | |
| EBITDA YoY % growth | N/A | -38.88M | -49.487M -27.28% | N/A | N/A | N/A | |
| EBIT YoY % growth | -400K 98.47% | -38.9M -9,625.00% | -49.554M -27.39% | -19.178M 61.30% | 26.605M 238.73% | 58.329M 119.24% | |
| Operating Margin | -1.39% | -648.33% | -117.16% | -16.78% | 14.40% | 24.94% | |
| EPS YoY % growth | 0.62 224.00% | -1.71 -375.81% | -1.72 -0.58% | -0.69 59.87% | 0.55 179.31% | 1.32 140.99% |
All data in USD
| Q4 / 22 | |
|---|---|
| EPS Q2Q % growth | -0.05 77.33% |
| Revenue Q2Q % growth | 36.075M 104.44% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -1.476M 76.05% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.09 70.00% | -0.18 | 0.09 | 49.87% |
| Q2 2022 Q2Q % growth | -0.24 40.00% | -0.29 | 0.05 | 15.97% |
| Q1 2022 Q2Q % growth | -0.30 62.96% | -0.25 | -0.05 | -18.60% |
| Q4 2021 Q2Q % growth | -0.21 52.27% | -0.29 | 0.08 | 28.39% |
| Q3 2021 Q2Q % growth | -0.30 9.09% | -0.37 | 0.07 | 18.86% |
| Q2 2021 Q2Q % growth | -0.40 4.76% | -0.46 | 0.06 | 12.85% |
| Q1 2021 Q2Q % growth | -0.81 -55.77% | -0.56 | -0.25 | -45.04% |
| Q4 2020 Q2Q % growth | -0.44 -57.14% | -0.39 | -0.05 | -13.52% |
| Q3 2020 Q2Q % growth | -0.33 -133.00% | -0.24 | -0.09 | -34.80% |
| Q2 2020 Q2Q % growth | -0.42 -110.00% | -0.52 | 0.10 | 18.73% |
| Q1 2020 Q2Q % growth | -0.52 -620.00% | -0.51 | -0.01 | -2.64% |
| Q4 2019 Q2Q % growth | -0.28 | -0.60 | 0.32 | 53.47% |
| Q3 2019 Q2Q % growth | 1.00 | 0.07 | 0.93 | 1,369.85% |
| Q2 2019 Q2Q % growth | -0.20 | -0.66 | 0.46 | 69.83% |
| Q1 2019 Q2Q % growth | 0.10 | -0.51 | 0.61 | 119.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 30.449M 100.68% | 30.14M | 309K | 1.03% |
| Q2 2022 Q2Q % growth | 25.304M 234.89% | 25.845M | -541K | -2.09% |
| Q1 2022 Q2Q % growth | 20.92M 1,001.05% | 21.064M | -144K | -0.68% |
| Q4 2021 Q2Q % growth | 17.646M 1,860.67% | 18.293M | -647K | -3.54% |
| Q3 2021 Q2Q % growth | 15.173M 321.47% | 14.075M | 1.098M | 7.80% |
| Q2 2021 Q2Q % growth | 7.556M 979.43% | 9.12M | -1.564M | -17.15% |
| Q1 2021 Q2Q % growth | 1.9M 137.50% | 1.032M | 868K | 84.11% |
| Q4 2020 Q2Q % growth | 900K 12.50% | 3.06M | -2.16M | -70.59% |
| Q3 2020 Q2Q % growth | 3.6M -85.99% | 3.023M | 577K | 19.09% |
| Q2 2020 Q2Q % growth | 700K | 1.378M | -678K | -49.20% |
| Q1 2020 Q2Q % growth | 800K -50.00% | 1.87M | -1.07M | -57.22% |
| Q4 2019 Q2Q % growth | 800K | 2.094M | -1.294M | -61.80% |
| Q3 2019 Q2Q % growth | 25.7M | 11.158M | 14.542M | 130.33% |
| Q2 2019 Q2Q % growth | 700K | 2.764M | -2.064M | -74.67% |
| Q1 2019 Q2Q % growth | 1.6M | 2.202M | -602K | -27.34% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 56.59% | 0% | 10.67% |
| Revenue | 0% | 2.59% | 0% | 1.76% |